Very early : Nothing is standard. Phone the folks at the National Cancer Institute and see if you can get into a study. Even if it does not help, you have advanced scientific knowledge for the next person.
Answered 5/10/2016
1.3k views
Pazopanib: Combination chemotherapy with doxorubicin and ifosfamide is standard and efficacious. We use pazopanib in second line to target VEGFR, FGFR, PDGFR, and other proteins. Also many targeted immunotherapies are in trials: https://clinicaltrials.sylvester.org
Answered 5/17/2017
709 views
3 doctors weighed in across 3 answers
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
4 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question